drugset / Trial / NCT06173596
A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults
Non-randomizedSingle-groupOpen-labelOther
Summary
The primary objectives of this study are to determine the effect of multiple doses of itraconazole on the single dose PK of ALXN2080, to determine the effect of multiple doses of fluconazole on the single dose PK of ALXN2080 (optional), and to determine the effect of multiple doses of carbamazepine on the single dose PK of ALXN2080.
Timeline
- Start
- 2024-01-10
- Primary completion
- 2024-04-30
- Completion
- 2024-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepine | Small molecule | — | Oral |
| Subject | Fluconazole | Small molecule | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | ZORACOPAN | Small molecule | — | Oral |
Indications
No indication recorded.